Production (Stage)
GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.04% | -42.40% | 0.85% | 58.64% | 1.09% |
| Total Depreciation and Amortization | -3.03% | -13.39% | -0.84% | -62.01% | -1.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.03% | 133.63% | 0.85% | -157.46% | -1.08% |
| Change in Net Operating Assets | -3.03% | 317.05% | 0.85% | -138.91% | -1.09% |
| Cash from Operations | 3.04% | 22.23% | 0.85% | 12.40% | 1.09% |
| Capital Expenditure | -- | 100.00% | 0.00% | 90.74% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -61.43% | -1.41% | -80.00% | -1.11% |
| Cash from Investing | 0.00% | -58.46% | 0.00% | -78.41% | -1.31% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | -511.30% | 0.00% | -39.86% | 0.00% |
| Issuance of Common Stock | 0.00% | -70.33% | 0.00% | 188.07% | 0.00% |
| Repurchase of Common Stock | 0.00% | 77.27% | 0.00% | 77.78% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -60.62% | 0.00% | 2,111.36% | 0.00% |
| Cash from Financing | -3.04% | -88.16% | -0.85% | 29.47% | -1.09% |
| Foreign Exchange rate Adjustments | 3.06% | -7,522.73% | 0.00% | -93.41% | -0.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00% |
| Net Change in Cash | 3.04% | -195.15% | -0.85% | 335.44% | -1.09% |